TrialHaematologica2018

Increased rituximab exposure does not improve response and outcome of patients with chronic lymphocytic leukemia after fludarabine, cyclophosphamide, rituximab. A French Innovative Leukemia Organization (FILO) study.

Guillaume Cartron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.